On Oct. 27, 2017, Clariant and Huntsman announced that they have jointly decided to cancel their planned merger due to the increased uncertainty around securing the required approval of two-thirds of Clariant's shareholders. Subsequently, on Oct. 31, 2017, Clariant announced healthy results for the third quarter to Sept. 30, 2017, with sales supported by the Catalysis and Care Chemicals divisions. We are therefore revising the outlook on Clariant to stable from positive, and affirming our 'BBB-' long-term and 'A-3' short-term corporate credit ratings on the company. The stable outlook reflects our view that Clariant will sustain reported EBITDA (after exceptional items) in 2017-2018 of about Swiss franc (CHF) 810 million–CHF850 million and that its cash flow generation will support ratios